These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2617082

  • 41. Von Willebrand factor antigen in assessment of vasculitis in patients with connective tissue diseases.
    Kloczko J, Kuryliszyn-Moskal A, Bernacka K, Bielawiec M, Cylwik B, Radziwon P.
    Clin Rheumatol; 1994 Mar; 13(1):34-8. PubMed ID: 8187441
    [Abstract] [Full Text] [Related]

  • 42. [The Willebrand factor in the diagnosis of hemostatic disorders in patients with rheumatoid arthritis].
    Demin AS.
    Lab Delo; 1991 Mar; (3):49-53. PubMed ID: 1710721
    [Abstract] [Full Text] [Related]

  • 43. Factor VIII von Willebrand protein in haemolytic uraemic syndrome and systemic vasculitides.
    Rose PE, Struthers GS, Robertson M, Kavi J, Chant I, Taylor CM.
    Lancet; 1990 Mar 03; 335(8688):500-2. PubMed ID: 1968528
    [Abstract] [Full Text] [Related]

  • 44. Vascular damage and factor-VIII-related antigen in the rheumatic diseases.
    Belch JJ, Zoma AA, Richards IM, McLaughlin K, Forbes CD, Sturrock RD.
    Rheumatol Int; 1987 Mar 03; 7(3):107-11. PubMed ID: 3118442
    [Abstract] [Full Text] [Related]

  • 45. [Serum uric acid levels in some rheumatic diseases (author's transl)].
    Bosmanský K, Trnavský K, Hajzoková M.
    Bratisl Lek Listy; 1981 May 03; 75(5):577-83. PubMed ID: 6972245
    [No Abstract] [Full Text] [Related]

  • 46. [Rheumatic diseases in hospital outpatients in Lome (Togo)].
    Mijiyawa MA, Djagnikpo AK, Agbanouvi AE, Koumouvi K, Agbetra A.
    Rev Rhum Mal Osteoartic; 1991 May 03; 58(5):349-54. PubMed ID: 2057725
    [Abstract] [Full Text] [Related]

  • 47. [Value and significance of the immunologic determination of various serum sialoglycoproteins in rheumatic diseases of inflammatory nature].
    Pappalardo A, Pulizzi C, Sossio M.
    Minerva Med; 1979 Sep 19; 70(39):2667-72. PubMed ID: 113711
    [Abstract] [Full Text] [Related]

  • 48. Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.
    Gurol G, Ciftci IH, Harman H, Karakece E, Kamanli A, Tekeoglu I.
    Int J Clin Exp Pathol; 2015 Sep 19; 8(2):1979-84. PubMed ID: 25973092
    [Abstract] [Full Text] [Related]

  • 49. Fibronectin and immune complexes in rheumatic diseases.
    Herbert KE, Coppock JS, Griffiths AM, Williams A, Robinson MW, Scott DL.
    Ann Rheum Dis; 1987 Oct 19; 46(10):734-40. PubMed ID: 3500676
    [Abstract] [Full Text] [Related]

  • 50. Factor VIII related antigen in the assessment of vasculitis.
    Woolf AD, Wakerley G, Wallington TB, Scott DG, Dieppe PA.
    Ann Rheum Dis; 1987 Jun 19; 46(6):441-7. PubMed ID: 3115202
    [Abstract] [Full Text] [Related]

  • 51. Von Willebrand factor, endothelial damage and ocular disease.
    Murray PI, Young DW, Aggarwal RK, Blann AD.
    Ocul Immunol Inflamm; 1993 Jun 19; 1(4):315-22. PubMed ID: 22822921
    [Abstract] [Full Text] [Related]

  • 52. Connective tissue activation. XXIII. Increased plasma levels of a platelet growth factor (CTAP-III) in patients with rheumatic diseases.
    MacCarter DK, Hossler PA, Castor CW.
    Clin Chim Acta; 1981 Sep 10; 115(2):125-34. PubMed ID: 6974622
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases.
    Sawyerr AM, Smith MS, Hall A, Hudson M, Hay CR, Wakefield AJ, Brook MG, Tomura H, Pounder RE.
    Dig Dis Sci; 1995 Apr 10; 40(4):793-9. PubMed ID: 7720471
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Pepsin homoreactant (agglutinator) in patients with rheumatoid arthritis and other rheumatic diseases].
    Mirakhmedova AKh, Bartova LM, Tarkhanova IA, Kul'berg AIa, Trofimova TM.
    Sov Med; 1977 Jul 10; (7):15-9. PubMed ID: 331491
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Vasculitis: mechanisms involved and clinical manifestations.
    Guillevin L, Dörner T.
    Arthritis Res Ther; 2007 Jul 10; 9 Suppl 2(Suppl 2):S9. PubMed ID: 17767747
    [Abstract] [Full Text] [Related]

  • 59. Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases.
    Sfikakis PP, Tsokos GC.
    Clin Diagn Lab Immunol; 1997 May 10; 4(3):241-6. PubMed ID: 9144356
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.